A Russian company is hoping to revolutionise the treatment of HIV patients around the world with the help of a grant from the Skolkovo Foundation. Currently, Russia's one million HIV patients take a daily cocktail of tablets. Viriom is working on...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...